Page 88 - SHB 2021 Issue 4

JSE – ASC Profile’s Stock Exchange Handbook: 2021 – Issue 4
Pharmaceuticals business comprises Sterile Focus and Regional Brands.
Ascendis Health Ltd. Aspen has invested in strategically relevant manufacturing capacity and
has capabilities across biological and chemical APIs, orals, liquids, topicals
ASC
ISIN: ZAE000185005 SHORT: ASCENDIS CODE: ASC and steriles, at 23 manufacturing facilities on 6 continents.
REG NO: 2008/005856/06 FOUNDED: 2008 LISTED: 2013 SECTOR: HlthCare—HtlhCare—Pharmaceutic&Biotech—Pharmaceuticals
NATURE OF BUSINESS: Ascendis Health is a South African-based NUMBER OF EMPLOYEES: 10 001
international health and wellness company marketing leading brands and DIRECTORS: de Beer PrfDr L (ind ne), KrugerBJ((ld ind ne),
products. Mkhwanazi T (ind ne), MortimerCN(ne), Ngonyama B (ind ne),
SECTOR: HlthCare—HtlhCare—Pharmaceutic&Biotech—Pharmaceuticals RedfernDS(ne), ZilwaSV(ind ne), Dlamini K D (Chair, ind ne),
NUMBER OF EMPLOYEES: 0 Saad S B (Group CE), Attridge M G (Deputy Group CE)
DIRECTORS: Harie B (ld ind ne), NtsalubaSS(ind ne), MAJOR ORDINARY SHAREHOLDERS as at 30 Jun 2020
PatherKS(ind ne), SebulelaJG(ind ne), Marshall A B (Chair, ind ne), Government Employees Pension Fund 15.70%
Sardi M (CEO), Kujenga C (CFO) Saad, SB 12.50%
MAJOR ORDINARY SHAREHOLDERS as at 07 Apr 2021 Attridge, MG 4.20%
International Finance Corporation 12.60% POSTAL ADDRESS: PO Box 1587, Gallo Manor, 2052
Kefolile Health Investments (Pty) Ltd. 6.80% MORE INFO: www.sharedata.co.za/sdo/jse/APN
Coast2Coast Capital (Pty) Ltd. 4.90% COMPANY SECRETARY: Riaan Verster
POSTAL ADDRESS:PostNetSuite252, PrivateBagX21,Bryanston,2021 TRANSFER SECRETARY: JSE Investor Services (Pty) Ltd.
MORE INFO: www.sharedata.co.za/sdo/jse/ASC SPONSOR: Investec Bank Ltd.
COMPANY SECRETARY: Mpeo Nkuna AUDITORS: PwC Inc.
TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
SPONSOR: Questco Corporate Advisory (Pty) Ltd. CAPITAL STRUCTURE AUTHORISED ISSUED
AUDITORS: PwC Inc. APN Ords no par value 717 600 000 456 451 541
DISTRIBUTIONS [ZARc]
CAPITAL STRUCTURE AUTHORISED ISSUED
ASC Ords no par value 2 000 000 000 489 469 959 Ords no par value Ldt Pay Amt
Final No 11 20 Sep 21 27 Sep 21 262.00
DISTRIBUTIONS [ZARc] Final No 10 2 Oct 18 8 Oct 18 315.00
Ords no par value Ldt Pay Amt
Interim No 6 9 May 17 15 May 17 11.00 LIQUIDITY: Oct21 Ave 6m shares p.w., R991.9m(72.3% p.a.)
Final No 5 29 Nov 16 5 Dec 16 12.00 PHAR 40 Week MA ASPEN
LIQUIDITY: Oct21 Ave 10m shares p.w., R7.2m(105.7% p.a.) 38000
PHAR 40 Week MA ASCENDIS
31787
2897
25574
2324
19361
1751
13148
1177
6935
2016 | 2017 | 2018 | 2019 | 2020 | 2021
604
FINANCIAL STATISTICS
31 (R million) Jun 21 Jun 20 Jun 19 Jun 18 Jun 17
2016 | 2017 | 2018 | 2019 | 2020 | 2021
Final Final(rst) Final(rst) Final(rst) Final(rst)
FINANCIAL STATISTICS Turnover 37 766 33 659 35 514 38 314 41 213
(R million) Jun 21 Jun 20 Jun 19 Jun 18 Jun 17 Op Inc 7 072 5 730 4 284 8 506 8 321
Final Final(rst) Final(rst) Final(rst) Final(rst)
Turnover 2 229 2 203 5 872 5 511 6 409 NetIntPd(Rcvd) 1 083 - 1 532 - 1 933 1 1 762 1 2 082 -
Minority Int
Op Inc - 450 - 896 - 1 245 480 734 Att Inc 4 806 4 664 6 463 6 037 5 128
NetIntPd(Rcvd) 1 080 788 403 353 307 TotCompIncLoss - 3 580 15 014 6 366 8 315 1 839
Minority Int 36 - 49 11 25 24 Fixed Ass 14 826 14 232 12 065 11 368 9 749
Att Inc - 1 091 - 966 - 4 710 257 283 Tot Curr Ass 32 643 36 738 36 152 39 493 37 363
TotCompIncLoss - 893 - 771 - 4 629 412 81 Ord SH Int 65 627 69 215 54 211 49 347 42 364
Fixed Ass 201 1 039 1 105 1 170 1 060 Minority Int - 2 2 28 27
Inv & Loans - - - 2 - LT Liab 7 306 45 873 48 064 54 532 38 396
Tot Curr Ass 1 253 4 353 4 672 4 709 4 240 Tot Curr Liab 36 700 18 079 20 039 28 200 34 806
Ord SH Int 347 1 294 1 840 6 613 5 141
Minority Int 167 127 169 162 155 PER SHARE STATISTICS (cents per share)
HEPS-C (ZARc) 1 204.30 998.10 1 158.10 1 383.50 1 299.50
LT Liab 250 7 908 915 5 969 6 115
Tot Curr Liab 7 545 2 464 8 365 3 118 3 132 DPS (ZARc) 262.00 - - 315.00 287.00
NAV PS (ZARc) 14 377.65 15 162.10 11 894.00 10 823.00 9 453.70
PER SHARE STATISTICS (cents per share) 3 Yr Beta 1.48 1.29 1.36 0.91 0.75
HEPS-C (ZARc) - 325.90 - 229.40 - 41.80 13.90 93.80 Price High 17 328 16 514 29 800 32 750 38 849
DPS (ZARc) - - - - 11.00 Price Low 10 298 6 407 6 899 22 987 25 564
NAV PS (ZARc) 71.97 270.91 379.60 1 431.34 1 246.95 Price Prd End 16 209 14 351 10 045 25 822 28 710
3 Yr Beta 2.56 2.17 1.61 0.99 1.47 RATIOS
Price High 92 570 1 200 2 290 2 939 Ret on SH Fnd 7.32 6.74 11.92 12.23 12.10
Price Low 43 29 305 801 2 020 Oper Pft Mgn 18.73 17.02 12.06 22.20 20.19
Price Prd End 58 84 470 1 090 2 164 D:E 0.49 0.75 1.04 1.33 1.35
RATIOS Current Ratio 0.89 2.03 1.80 1.40 1.07
Ret on SH Fnd - 205.34 - 71.45 - 233.92 4.17 5.80 Div Cover 4.02 - - 4.20 3.91
Oper Pft Mgn - 20.21 - 40.68 - 21.21 8.71 11.46
D:E 13.69 5.98 3.22 1.03 1.37
Current Ratio 0.17 1.77 0.56 1.51 1.35 Astoria Investment Ltd.
Div Cover - - - - 6.25 AST
ISIN: MU0499N00015 SHORT: ASTORIA CODE: ARA
REG NO: 1297585 C1/GBL FOUNDED: 2015 LISTED: 2015
Aspen Pharmacare Holdings Ltd. NATURE OF BUSINESS: Astoria is a global investment company which
inward listed on the JSE in November 2015. The objective of the company
ASP
ISIN: ZAE000066692 SHORT: ASPEN CODE: APN is to deliver a sustained, strong compound growth in value per share in
REG NO: 1985/002935/06 FOUNDED: 1850 LISTED: 1998 USD. The company investsin global, high quality equities, niche fundsand
NATURE OF BUSINESS: Aspen Pharmacare Holdings Ltd, is a South private equity.
African-basedglobalspecialty pharmaceutical companywithacommercial SECTOR: AltX
footprint covering more than 50 countries and complex manufacturing NUMBER OF EMPLOYEES: 0
capabilities in both API and finished dose form. The company focuses on a DIRECTORS: De Chasteigner Du MéeCJ(ne, Mau), HardyNF(ind ne,
broad range of post-patent, branded medicines and domestic brands Mau), JorgensenCJ(ind ne), Rosevear D (alt), McIlraith C
spanning many therapeutic areas. The Group's Commercial (Chair, ind ne, Mau), Schweizer D (CFO)
86